TY - JOUR AU - Tirelli, Umberto AU - Carbone, Antonino AU - Di Francia, Raffaele AU - Berretta, Massimiliano PY - 2019 TI - A new peg-filgrastim biosimilar, mecapegfilgrastim for primary prophylaxis of chemotherapy-related neutropenia is now available JF - Annals of Translational Medicine; Vol 8, No 5 (March 17, 2020): Annals of Translational Medicine Y2 - 2019 KW - N2 - Chemotherapy is still one of the main tools for treatment of pediatric and adult blood and solid tumors and is capable of cure some acute leukemia, some advanced lymphomas, advanced testicular cancers among others (1). However, the main side effects and limiting factors for its use is myelotoxicity, in particular neutropenia and eventual life threatening febrile neutropenia. UR - https://atm.amegroups.org/article/view/30998